SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #1,735CAS 2区Hybrid

Pharmacoeconomics

Abbreviation (ISO):PHARMACOECONOMICS
Country: New Zealand•WoS SCIE Quartile: Q1•Scopus SJR: 1.807•SCImago Rank: #1,735•Identifier (ISSN):1170-7690(Print)/1179-2027(Online)•Articles / Year: 108•Estimated Publication Fee (APC): $3,623 USD
Clarivate IF (2026)Q1
4.7
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
91

91 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate9.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
108articles/year
70.85% Gold OA•72.94% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

2.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 3.0(IF: 4.7)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20262.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.7)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.6)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.4)
🔵 Computed
20232.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.4)
🔵 Computed
20222.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.558)
🔵 Computed
20212.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.981)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.563)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.705)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.989)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative and practical articles on the application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes. An invaluable source of applied pharmacoeconomic original research and educational material for the healthcare decision maker. PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to patient care and drug utilization. PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article.

Topics Covered (Recognized by AI)
Medicine98.3%Pathology87.1%Economics85.5%Political science76.7%Nursing76.7%Law76.7%Biology72%Public health70.4%Economic growth69.8%Health care68.9%Health economics64%Business55.7%Internal medicine54.6%Mathematics47.6%Statistics42%Psychology39.6%Health administration38.1%Engineering37.9%Management35.6%Quality of Life Research34.5%Intensive care medicine33.8%Microeconomics32.8%Risk analysis (engineering)32.1%Operations management29.3%Cost effectiveness27.7%Psychiatry27.6%Computer science25.9%Chemistry25.5%Genetics24.3%Biochemistry22.6%Surgery22.3%Environmental health21.9%Ecology21.5%Sociology20.9%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,735Scopus Q1SCImago Profile
Scopus Coverage:1992-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.807

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
127

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
5.09

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,623 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,637
3-Year Documents326
Citable Documents291

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate45.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Health PolicyQ1
PharmacologyQ1
Public Health, Environmental and Occupational HealthQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ECONOMICS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer International Publishing
Publication Language
English
Frequency
Monthly
Founding Year
1992
Editorial Address
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311
Indexing & Databases
SCIESSCIScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ECONOMICS
JCRSSCI
62/626Q1
HEALTH CARE SCIENCES & SERVICES
JCRSCIE
29/194Q1
HEALTH POLICY & SERVICES
JCRSSCI
9/125Q1
PHARMACOLOGY & PHARMACY
JCRSCIE
78/356Q1
ECONOMICS
JCISSCI
81/627Q1
HEALTH CARE SCIENCES & SERVICES
JCISCIE
24/194Q1
HEALTH POLICY & SERVICES
JCISSCI
10/125Q1
PHARMACOLOGY & PHARMACY
JCISCIE
44/356Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—8830
20254.6110335
20244.4122816
20234.41111,763
20224.5581062,447
20214.9811313,791
20203.5631293,795
20193.7051143,176
20183.9891426,344
2017—1184,585
2016—1306,010
2015—1115,460
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Pharmacoeconomics

WoS Q1
2356201820192020202120222023202420254.60
Annual Impact Factor Metric
2025:4.6

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 9.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 9dc88354-cbfd-4504-8cb9-c79f3b5ca680
Database Updated: 2026-10-01